Singapore markets closed

ACADIA Pharmaceuticals Inc. (0A4W.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
15.05+0.23 (+1.55%)
As of 05:43PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-5.27%
S&P500 52-week change 324.71%
52-week high 333.96
52-week low 30.00
50-day moving average 326.24
200-day moving average 325.52

Share statistics

Avg vol (3-month) 31.56k
Avg vol (10-day) 32.38k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8107.62M
% held by insiders 10.51%
% held by institutions 1100.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.21%
Operating margin (ttm)7.39%

Management effectiveness

Return on assets (ttm)-0.38%
Return on equity (ttm)-0.41%

Income statement

Revenue (ttm)813.81M
Revenue per share (ttm)4.95
Quarterly revenue growth (yoy)73.80%
Gross profit (ttm)N/A
EBITDA 6.07M
Net income avi to common (ttm)-1.71M
Diluted EPS (ttm)-1.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)470.52M
Total cash per share (mrq)2.85
Total debt (mrq)59.64M
Total debt/equity (mrq)12.85%
Current ratio (mrq)2.04
Book value per share (mrq)2.81

Cash flow statement

Operating cash flow (ttm)63.71M
Levered free cash flow (ttm)34.42M